SCHEMBL31409528

SCHEMBL31409528

CCN1Cc2cc(O)ccc2C1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 1/20 0.48
PRMT5 O14744 1/20 0.44
WDR77 Q9BQA1 1/20 0.44
CRBN Q96SW2 1/20 0.44
PRF1 P14222 1/20 0.42
MEN1 O00255 2/20 0.41
GLA P06280 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 2/20 0.41
ALOX15 P16050 2/20 0.41
TSHR P16473 2/20 0.41
GAA P10253 1/20 0.41
NPC1 O15118 1/20 0.41
NR1I2 O75469 1/20 0.41
GMNN O75496 1/20 0.41
USP2 O75604 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2499130 0.84 GRM5 (0.46) ADAM17PRMT5WDR77CRBNPRF1
SCHEMBL29438592 0.84 PRMT5 (0.48) PRMT5WDR77CYP2D6MAOAMAOB
SCHEMBL471625 0.84 PRMT5 (0.48) PRMT5WDR77CYP2D6MAOAMAOB
SCHEMBL22151770 0.83 ADAM17 (0.48) ADAM17PRMT5WDR77PRF1GRM5
SCHEMBL31409552 0.83 ADAM17 (0.46) ADAM17PRMT5WDR77CRBNMEN1
SCHEMBL6440457 0.82 ADAM17 (0.47) ADAM17PRMT5WDR77CRBNPRF1
SCHEMBL6071228 0.81 PRMT5 (0.55) ADAM17PRMT5WDR77MAOAMAOB
SCHEMBL1026421 0.81 GRM5 (0.44) PRF1MEN1KMT2AKDM4EALOX15
SCHEMBL21481250 0.80 HTR2A (0.46) PRF1MEN1KMT2AKDM4EALOX15
SCHEMBL1029578 0.80 HSD17B3 (0.49) PRMT5WDR77PRF1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025006553-A1 METABOTROPIC GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATORS AND USES THEREOF Sanford Burnham Prebys Medical Discovery Institute (US) 2025-01-02 WO disclosed